Assetmark »

Travere Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2025-12-31 $824k 22k 38.21

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Microsoft Corporation (MSFT)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Meta Platforms Cl A (META)

View all positions for Assetmark

Top funds holding Travere Therapeutics

FMR
BlackRock
Vanguard Group
State Street Corporation
Perceptive Advisors
Adage Capital Partners GP
Renaissance Technologies
Rock Springs Capital Management
Geode Capital Management
Goldman Sachs Group
Stephens Investment Management Group
Emerald Advisers
Point72 Asset Management
Eversept Partners
Two Sigma Investments

View all funds holding Travere Therapeutics